Five things for pharma marketers to know: Monday, September 14, 2015

Entresto's price is too high; Shire may increase its bid for Baxalta; Sanofi's experimental diabetes drug LixiLan met its late-stage trial target

from Most popular articles from Medical Marketing and Media http://ift.tt/1W1Jpb1